LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Other
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Deferred Tax Assets, Other of $7.78 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Other $7.78M.
- 2024-12-31: Deferred Tax Assets, Other $13.73M.
- 2023-12-31: Deferred Tax Assets, Other $15.01M.
- 2022-12-31: Deferred Tax Assets, Other $14.85M; Deferred Tax Assets, Other as first filed $19.54M.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2025-12-31 | $7.78M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $13.73M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $15.01M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $14.85M 10-K · filed 2024-02-29 | $19.54M 10-K · filed 2023-02-28 |
| 2021-12-31 | $12.99M 10-K · filed 2023-02-28 | $19.67M 10-K · filed 2022-02-28 |
| 2020-12-31 | $13.12M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $10.60M 10-K · filed 2021-02-24 | $17.96M 10-K · filed 2020-02-27 |
| 2018-12-31 | $11.43M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $12.50M 10-K · filed 2019-02-28 | $12.12M 10-K · filed 2018-03-01 |
| 2016-12-31 | $19.31M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $15.44M 10-K · filed 2017-02-28 | $17.28M 10-K · filed 2016-02-26 |
| 2014-12-31 | $5.78M 10-K · filed 2016-11-14 | $3.70M 10-K · filed 2014-12-01 |
| 2013-12-31 | $3.70M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $1.84M 10-K/A · filed 2014-12-12 | |
| 2011-12-31 | $2.62M 10-K · filed 2013-03-14 |